0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global COPD and Asthma Devices Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-14C7239
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global COPD and Asthma Devices Market Insights and Forecast to 2028
BUY CHAPTERS

Global COPD and Asthma Devices Market Research Report 2024

Code: QYRE-Auto-14C7239
Report
March 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

COPD and Asthma Devices Market

Chronic obstructive pulmonary disease (COPD) and asthma devices are useful in inhalation therapy and assist in drug delivery by converting drug suspensions or solutions to aerosolized particles.
The global COPD and Asthma Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices.
This report aims to provide a comprehensive presentation of the global market for COPD and Asthma Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COPD and Asthma Devices.

Report Scope

The COPD and Asthma Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COPD and Asthma Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COPD and Asthma Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of COPD and Asthma Devices Market Report

Report Metric Details
Report Name COPD and Asthma Devices Market
Segment by Type
  • Metered Dose Inhalers (MDI)
  • Drug Powder Inhalers (DPI)
  • Soft Mist Inhalers
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc, AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc, Sunovion Pharmaceuticals Inc, GF Healthcare Products, Smith Medicals, Lincare Holdings Inc, Baxter International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of COPD and Asthma Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of COPD and Asthma Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the COPD and Asthma Devices Market report?

Ans: The main players in the COPD and Asthma Devices Market are GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc, AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc, Sunovion Pharmaceuticals Inc, GF Healthcare Products, Smith Medicals, Lincare Holdings Inc, Baxter International

What are the Application segmentation covered in the COPD and Asthma Devices Market report?

Ans: The Applications covered in the COPD and Asthma Devices Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the COPD and Asthma Devices Market report?

Ans: The Types covered in the COPD and Asthma Devices Market report are Metered Dose Inhalers (MDI), Drug Powder Inhalers (DPI), Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Others

1 COPD and Asthma Devices Market Overview
1.1 Product Overview and Scope of COPD and Asthma Devices
1.2 COPD and Asthma Devices Segment by Type
1.2.1 Global COPD and Asthma Devices Market Value Comparison by Type (2024-2030)
1.2.2 Metered Dose Inhalers (MDI)
1.2.3 Drug Powder Inhalers (DPI)
1.2.4 Soft Mist Inhalers
1.2.5 Jet Nebulizers
1.2.6 Ultrasonic Nebulizers
1.2.7 Others
1.3 COPD and Asthma Devices Segment by Application
1.3.1 Global COPD and Asthma Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global COPD and Asthma Devices Market Size Estimates and Forecasts
1.4.1 Global COPD and Asthma Devices Revenue 2019-2030
1.4.2 Global COPD and Asthma Devices Sales 2019-2030
1.4.3 Global COPD and Asthma Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 COPD and Asthma Devices Market Competition by Manufacturers
2.1 Global COPD and Asthma Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global COPD and Asthma Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global COPD and Asthma Devices Average Price by Manufacturers (2019-2024)
2.4 Global COPD and Asthma Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of COPD and Asthma Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of COPD and Asthma Devices, Product Type & Application
2.7 COPD and Asthma Devices Market Competitive Situation and Trends
2.7.1 COPD and Asthma Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest COPD and Asthma Devices Players Market Share by Revenue
2.7.3 Global COPD and Asthma Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 COPD and Asthma Devices Retrospective Market Scenario by Region
3.1 Global COPD and Asthma Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global COPD and Asthma Devices Global COPD and Asthma Devices Sales by Region: 2019-2030
3.2.1 Global COPD and Asthma Devices Sales by Region: 2019-2024
3.2.2 Global COPD and Asthma Devices Sales by Region: 2025-2030
3.3 Global COPD and Asthma Devices Global COPD and Asthma Devices Revenue by Region: 2019-2030
3.3.1 Global COPD and Asthma Devices Revenue by Region: 2019-2024
3.3.2 Global COPD and Asthma Devices Revenue by Region: 2025-2030
3.4 North America COPD and Asthma Devices Market Facts & Figures by Country
3.4.1 North America COPD and Asthma Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America COPD and Asthma Devices Sales by Country (2019-2030)
3.4.3 North America COPD and Asthma Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe COPD and Asthma Devices Market Facts & Figures by Country
3.5.1 Europe COPD and Asthma Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe COPD and Asthma Devices Sales by Country (2019-2030)
3.5.3 Europe COPD and Asthma Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COPD and Asthma Devices Market Facts & Figures by Country
3.6.1 Asia Pacific COPD and Asthma Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific COPD and Asthma Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific COPD and Asthma Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America COPD and Asthma Devices Market Facts & Figures by Country
3.7.1 Latin America COPD and Asthma Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America COPD and Asthma Devices Sales by Country (2019-2030)
3.7.3 Latin America COPD and Asthma Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COPD and Asthma Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa COPD and Asthma Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa COPD and Asthma Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa COPD and Asthma Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COPD and Asthma Devices Sales by Type (2019-2030)
4.1.1 Global COPD and Asthma Devices Sales by Type (2019-2024)
4.1.2 Global COPD and Asthma Devices Sales by Type (2025-2030)
4.1.3 Global COPD and Asthma Devices Sales Market Share by Type (2019-2030)
4.2 Global COPD and Asthma Devices Revenue by Type (2019-2030)
4.2.1 Global COPD and Asthma Devices Revenue by Type (2019-2024)
4.2.2 Global COPD and Asthma Devices Revenue by Type (2025-2030)
4.2.3 Global COPD and Asthma Devices Revenue Market Share by Type (2019-2030)
4.3 Global COPD and Asthma Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global COPD and Asthma Devices Sales by Application (2019-2030)
5.1.1 Global COPD and Asthma Devices Sales by Application (2019-2024)
5.1.2 Global COPD and Asthma Devices Sales by Application (2025-2030)
5.1.3 Global COPD and Asthma Devices Sales Market Share by Application (2019-2030)
5.2 Global COPD and Asthma Devices Revenue by Application (2019-2030)
5.2.1 Global COPD and Asthma Devices Revenue by Application (2019-2024)
5.2.2 Global COPD and Asthma Devices Revenue by Application (2025-2030)
5.2.3 Global COPD and Asthma Devices Revenue Market Share by Application (2019-2030)
5.3 Global COPD and Asthma Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline Plc
6.1.1 GlaxoSmithKline Plc Corporation Information
6.1.2 GlaxoSmithKline Plc Description and Business Overview
6.1.3 GlaxoSmithKline Plc COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Plc COPD and Asthma Devices Product Portfolio
6.1.5 GlaxoSmithKline Plc Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis AG COPD and Asthma Devices Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Merck & Co., Inc
6.3.1 Merck & Co., Inc Corporation Information
6.3.2 Merck & Co., Inc Description and Business Overview
6.3.3 Merck & Co., Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co., Inc COPD and Asthma Devices Product Portfolio
6.3.5 Merck & Co., Inc Recent Developments/Updates
6.4 AstraZeneca Plc
6.4.1 AstraZeneca Plc Corporation Information
6.4.2 AstraZeneca Plc Description and Business Overview
6.4.3 AstraZeneca Plc COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Plc COPD and Asthma Devices Product Portfolio
6.4.5 AstraZeneca Plc Recent Developments/Updates
6.5 Philips Healthcare
6.5.1 Philips Healthcare Corporation Information
6.5.2 Philips Healthcare Description and Business Overview
6.5.3 Philips Healthcare COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Philips Healthcare COPD and Asthma Devices Product Portfolio
6.5.5 Philips Healthcare Recent Developments/Updates
6.6 3M Health Care
6.6.1 3M Health Care Corporation Information
6.6.2 3M Health Care Description and Business Overview
6.6.3 3M Health Care COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 3M Health Care COPD and Asthma Devices Product Portfolio
6.6.5 3M Health Care Recent Developments/Updates
6.7 Allied Healthcare Products Inc
6.6.1 Allied Healthcare Products Inc Corporation Information
6.6.2 Allied Healthcare Products Inc Description and Business Overview
6.6.3 Allied Healthcare Products Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allied Healthcare Products Inc COPD and Asthma Devices Product Portfolio
6.7.5 Allied Healthcare Products Inc Recent Developments/Updates
6.8 Sunovion Pharmaceuticals Inc
6.8.1 Sunovion Pharmaceuticals Inc Corporation Information
6.8.2 Sunovion Pharmaceuticals Inc Description and Business Overview
6.8.3 Sunovion Pharmaceuticals Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sunovion Pharmaceuticals Inc COPD and Asthma Devices Product Portfolio
6.8.5 Sunovion Pharmaceuticals Inc Recent Developments/Updates
6.9 GF Healthcare Products
6.9.1 GF Healthcare Products Corporation Information
6.9.2 GF Healthcare Products Description and Business Overview
6.9.3 GF Healthcare Products COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 GF Healthcare Products COPD and Asthma Devices Product Portfolio
6.9.5 GF Healthcare Products Recent Developments/Updates
6.10 Smith Medicals
6.10.1 Smith Medicals Corporation Information
6.10.2 Smith Medicals Description and Business Overview
6.10.3 Smith Medicals COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Smith Medicals COPD and Asthma Devices Product Portfolio
6.10.5 Smith Medicals Recent Developments/Updates
6.11 Lincare Holdings Inc
6.11.1 Lincare Holdings Inc Corporation Information
6.11.2 Lincare Holdings Inc COPD and Asthma Devices Description and Business Overview
6.11.3 Lincare Holdings Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lincare Holdings Inc COPD and Asthma Devices Product Portfolio
6.11.5 Lincare Holdings Inc Recent Developments/Updates
6.12 Baxter International
6.12.1 Baxter International Corporation Information
6.12.2 Baxter International COPD and Asthma Devices Description and Business Overview
6.12.3 Baxter International COPD and Asthma Devices Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Baxter International COPD and Asthma Devices Product Portfolio
6.12.5 Baxter International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COPD and Asthma Devices Industry Chain Analysis
7.2 COPD and Asthma Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COPD and Asthma Devices Production Mode & Process
7.4 COPD and Asthma Devices Sales and Marketing
7.4.1 COPD and Asthma Devices Sales Channels
7.4.2 COPD and Asthma Devices Distributors
7.5 COPD and Asthma Devices Customers
8 COPD and Asthma Devices Market Dynamics
8.1 COPD and Asthma Devices Industry Trends
8.2 COPD and Asthma Devices Market Drivers
8.3 COPD and Asthma Devices Market Challenges
8.4 COPD and Asthma Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global COPD and Asthma Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global COPD and Asthma Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global COPD and Asthma Devices Market Competitive Situation by Manufacturers in 2023
    Table 4. Global COPD and Asthma Devices Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global COPD and Asthma Devices Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global COPD and Asthma Devices Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global COPD and Asthma Devices Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market COPD and Asthma Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of COPD and Asthma Devices, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of COPD and Asthma Devices, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of COPD and Asthma Devices, Product Type & Application
    Table 12. Global Key Manufacturers of COPD and Asthma Devices, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global COPD and Asthma Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD and Asthma Devices as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global COPD and Asthma Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global COPD and Asthma Devices Sales by Region (2019-2024) & (K Units)
    Table 18. Global COPD and Asthma Devices Sales Market Share by Region (2019-2024)
    Table 19. Global COPD and Asthma Devices Sales by Region (2025-2030) & (K Units)
    Table 20. Global COPD and Asthma Devices Sales Market Share by Region (2025-2030)
    Table 21. Global COPD and Asthma Devices Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global COPD and Asthma Devices Revenue Market Share by Region (2019-2024)
    Table 23. Global COPD and Asthma Devices Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global COPD and Asthma Devices Revenue Market Share by Region (2025-2030)
    Table 25. North America COPD and Asthma Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America COPD and Asthma Devices Sales by Country (2019-2024) & (K Units)
    Table 27. North America COPD and Asthma Devices Sales by Country (2025-2030) & (K Units)
    Table 28. North America COPD and Asthma Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America COPD and Asthma Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe COPD and Asthma Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe COPD and Asthma Devices Sales by Country (2019-2024) & (K Units)
    Table 32. Europe COPD and Asthma Devices Sales by Country (2025-2030) & (K Units)
    Table 33. Europe COPD and Asthma Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe COPD and Asthma Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific COPD and Asthma Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific COPD and Asthma Devices Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific COPD and Asthma Devices Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific COPD and Asthma Devices Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific COPD and Asthma Devices Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America COPD and Asthma Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America COPD and Asthma Devices Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America COPD and Asthma Devices Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America COPD and Asthma Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America COPD and Asthma Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa COPD and Asthma Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa COPD and Asthma Devices Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa COPD and Asthma Devices Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa COPD and Asthma Devices Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa COPD and Asthma Devices Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global COPD and Asthma Devices Sales (K Units) by Type (2019-2024)
    Table 51. Global COPD and Asthma Devices Sales (K Units) by Type (2025-2030)
    Table 52. Global COPD and Asthma Devices Sales Market Share by Type (2019-2024)
    Table 53. Global COPD and Asthma Devices Sales Market Share by Type (2025-2030)
    Table 54. Global COPD and Asthma Devices Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global COPD and Asthma Devices Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global COPD and Asthma Devices Revenue Market Share by Type (2019-2024)
    Table 57. Global COPD and Asthma Devices Revenue Market Share by Type (2025-2030)
    Table 58. Global COPD and Asthma Devices Price (USD/Unit) by Type (2019-2024)
    Table 59. Global COPD and Asthma Devices Price (USD/Unit) by Type (2025-2030)
    Table 60. Global COPD and Asthma Devices Sales (K Units) by Application (2019-2024)
    Table 61. Global COPD and Asthma Devices Sales (K Units) by Application (2025-2030)
    Table 62. Global COPD and Asthma Devices Sales Market Share by Application (2019-2024)
    Table 63. Global COPD and Asthma Devices Sales Market Share by Application (2025-2030)
    Table 64. Global COPD and Asthma Devices Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global COPD and Asthma Devices Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global COPD and Asthma Devices Revenue Market Share by Application (2019-2024)
    Table 67. Global COPD and Asthma Devices Revenue Market Share by Application (2025-2030)
    Table 68. Global COPD and Asthma Devices Price (USD/Unit) by Application (2019-2024)
    Table 69. Global COPD and Asthma Devices Price (USD/Unit) by Application (2025-2030)
    Table 70. GlaxoSmithKline Plc Corporation Information
    Table 71. GlaxoSmithKline Plc Description and Business Overview
    Table 72. GlaxoSmithKline Plc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. GlaxoSmithKline Plc COPD and Asthma Devices Product
    Table 74. GlaxoSmithKline Plc Recent Developments/Updates
    Table 75. Novartis AG Corporation Information
    Table 76. Novartis AG Description and Business Overview
    Table 77. Novartis AG COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Novartis AG COPD and Asthma Devices Product
    Table 79. Novartis AG Recent Developments/Updates
    Table 80. Merck & Co., Inc Corporation Information
    Table 81. Merck & Co., Inc Description and Business Overview
    Table 82. Merck & Co., Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Merck & Co., Inc COPD and Asthma Devices Product
    Table 84. Merck & Co., Inc Recent Developments/Updates
    Table 85. AstraZeneca Plc Corporation Information
    Table 86. AstraZeneca Plc Description and Business Overview
    Table 87. AstraZeneca Plc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. AstraZeneca Plc COPD and Asthma Devices Product
    Table 89. AstraZeneca Plc Recent Developments/Updates
    Table 90. Philips Healthcare Corporation Information
    Table 91. Philips Healthcare Description and Business Overview
    Table 92. Philips Healthcare COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Philips Healthcare COPD and Asthma Devices Product
    Table 94. Philips Healthcare Recent Developments/Updates
    Table 95. 3M Health Care Corporation Information
    Table 96. 3M Health Care Description and Business Overview
    Table 97. 3M Health Care COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. 3M Health Care COPD and Asthma Devices Product
    Table 99. 3M Health Care Recent Developments/Updates
    Table 100. Allied Healthcare Products Inc Corporation Information
    Table 101. Allied Healthcare Products Inc Description and Business Overview
    Table 102. Allied Healthcare Products Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Allied Healthcare Products Inc COPD and Asthma Devices Product
    Table 104. Allied Healthcare Products Inc Recent Developments/Updates
    Table 105. Sunovion Pharmaceuticals Inc Corporation Information
    Table 106. Sunovion Pharmaceuticals Inc Description and Business Overview
    Table 107. Sunovion Pharmaceuticals Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Sunovion Pharmaceuticals Inc COPD and Asthma Devices Product
    Table 109. Sunovion Pharmaceuticals Inc Recent Developments/Updates
    Table 110. GF Healthcare Products Corporation Information
    Table 111. GF Healthcare Products Description and Business Overview
    Table 112. GF Healthcare Products COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. GF Healthcare Products COPD and Asthma Devices Product
    Table 114. GF Healthcare Products Recent Developments/Updates
    Table 115. Smith Medicals Corporation Information
    Table 116. Smith Medicals Description and Business Overview
    Table 117. Smith Medicals COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Smith Medicals COPD and Asthma Devices Product
    Table 119. Smith Medicals Recent Developments/Updates
    Table 120. Lincare Holdings Inc Corporation Information
    Table 121. Lincare Holdings Inc Description and Business Overview
    Table 122. Lincare Holdings Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. Lincare Holdings Inc COPD and Asthma Devices Product
    Table 124. Lincare Holdings Inc Recent Developments/Updates
    Table 125. Baxter International Corporation Information
    Table 126. Baxter International Description and Business Overview
    Table 127. Baxter International COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 128. Baxter International COPD and Asthma Devices Product
    Table 129. Baxter International Recent Developments/Updates
    Table 130. Key Raw Materials Lists
    Table 131. Raw Materials Key Suppliers Lists
    Table 132. COPD and Asthma Devices Distributors List
    Table 133. COPD and Asthma Devices Customers List
    Table 134. COPD and Asthma Devices Market Trends
    Table 135. COPD and Asthma Devices Market Drivers
    Table 136. COPD and Asthma Devices Market Challenges
    Table 137. COPD and Asthma Devices Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of COPD and Asthma Devices
    Figure 2. Global COPD and Asthma Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global COPD and Asthma Devices Market Share by Type in 2023 & 2030
    Figure 4. Metered Dose Inhalers (MDI) Product Picture
    Figure 5. Drug Powder Inhalers (DPI) Product Picture
    Figure 6. Soft Mist Inhalers Product Picture
    Figure 7. Jet Nebulizers Product Picture
    Figure 8. Ultrasonic Nebulizers Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global COPD and Asthma Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global COPD and Asthma Devices Market Share by Application in 2023 & 2030
    Figure 12. Hospitals
    Figure 13. Clinics
    Figure 14. Others
    Figure 15. Global COPD and Asthma Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global COPD and Asthma Devices Market Size (2019-2030) & (US$ Million)
    Figure 17. Global COPD and Asthma Devices Sales (2019-2030) & (K Units)
    Figure 18. Global COPD and Asthma Devices Average Price (USD/Unit) & (2019-2030)
    Figure 19. COPD and Asthma Devices Report Years Considered
    Figure 20. COPD and Asthma Devices Sales Share by Manufacturers in 2023
    Figure 21. Global COPD and Asthma Devices Revenue Share by Manufacturers in 2023
    Figure 22. The Global 5 and 10 Largest COPD and Asthma Devices Players: Market Share by Revenue in 2023
    Figure 23. COPD and Asthma Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 24. Global COPD and Asthma Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 25. North America COPD and Asthma Devices Sales Market Share by Country (2019-2030)
    Figure 26. North America COPD and Asthma Devices Revenue Market Share by Country (2019-2030)
    Figure 27. U.S. COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Canada COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Europe COPD and Asthma Devices Sales Market Share by Country (2019-2030)
    Figure 30. Europe COPD and Asthma Devices Revenue Market Share by Country (2019-2030)
    Figure 31. Germany COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. France COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. U.K. COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Italy COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Russia COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Asia Pacific COPD and Asthma Devices Sales Market Share by Region (2019-2030)
    Figure 37. Asia Pacific COPD and Asthma Devices Revenue Market Share by Region (2019-2030)
    Figure 38. China COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Japan COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. South Korea COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. India COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Australia COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Taiwan COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Indonesia COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Thailand COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Malaysia COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Philippines COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Latin America COPD and Asthma Devices Sales Market Share by Country (2019-2030)
    Figure 49. Latin America COPD and Asthma Devices Revenue Market Share by Country (2019-2030)
    Figure 50. Mexico COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Brazil COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Argentina COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Middle East & Africa COPD and Asthma Devices Sales Market Share by Country (2019-2030)
    Figure 54. Middle East & Africa COPD and Asthma Devices Revenue Market Share by Country (2019-2030)
    Figure 55. Turkey COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. UAE COPD and Asthma Devices Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. Global Sales Market Share of COPD and Asthma Devices by Type (2019-2030)
    Figure 59. Global Revenue Market Share of COPD and Asthma Devices by Type (2019-2030)
    Figure 60. Global COPD and Asthma Devices Price (USD/Unit) by Type (2019-2030)
    Figure 61. Global Sales Market Share of COPD and Asthma Devices by Application (2019-2030)
    Figure 62. Global Revenue Market Share of COPD and Asthma Devices by Application (2019-2030)
    Figure 63. Global COPD and Asthma Devices Price (USD/Unit) by Application (2019-2030)
    Figure 64. COPD and Asthma Devices Value Chain
    Figure 65. COPD and Asthma Devices Production Process
    Figure 66. Channels of Distribution (Direct Vs Distribution)
    Figure 67. Distributors Profiles
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Family Asthma Management Product Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33S10320
Sun Apr 07 00:00:00 UTC 2024

Add to Cart

Global Disposable Oropharyngeal Airway Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25D8684
Wed Mar 20 00:00:00 UTC 2024

Add to Cart

Global PC-Based Spirometer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37U6932
Wed Mar 20 00:00:00 UTC 2024

Add to Cart

Global Respiratory Assistance Devices Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24S8616
Wed Mar 20 00:00:00 UTC 2024

Add to Cart